U.S. President Donald Trump and Germany’s Merck KGaA have struck a deal to cut the cost of in-vitro fertilization drugs in exchange for protection from tariffs. The agreement also includes Merck offering new drugs at the same prices as in other developed countries, and expanding insurance coverage for fertility care.